Role of thrombotic and fibrinolytic factors in acute coronary syndromes.
There is a growing body of literature concerning the contribution of hemostatic factors to the development of cardiovascular disease. The mechanisms of the coagulation/fibrinolytic system are complicated and one factor is intimately interrelated with another; thus the contribution of each factor cannot be clearly understood, unless hemostatic factors are considered in accordance with endothelial function and vessel morphology. Although there are many clinical studies about the correlation between hemostatic factors and cardiovascular risk, the results are inconsistent and conflicting at times. Fibrinogen and D-dimer are associated with atherosclerosis or coronary events across multiple studies, even after multivariate adjustment. But the hemostatic factors are intimately correlated, so it can be said that focusing on one to the exclusion of others is inappropriate. The clinical trials with statins or angiotensin converting enzyme inhibitors have shown favorable effects on the prognosis of cardiovascular disease. The study of hemostatic factors in relation to these drugs has provided insights into understanding how these drugs produce beneficial effects.
Saigo
Masahiko
M
Division of Cardiology, San Francisco General Hospital, and Department of Medicine, University of California, San Francisco, USA.
Hsue
Priscilla Y
PY
Waters
David D
DD
D000208:Acute Disease; D001779:Blood Coagulation Factors / Q000378:metabolism / Q000502:physiology; D003327:Coronary Disease / Q000378:metabolism / Q000503:physiopathology*; D003328:Coronary Thrombosis / Q000209:etiology* / Q000378:metabolism / Q000503:physiopathology*; D004730:Endothelium, Vascular / Q000378:metabolism / Q000503:physiopathology; D005342:Fibrinolysis / Q000502:physiology*; D005343:Fibrinolytic Agents / Q000378:metabolism* / Q000494:pharmacology; D006801:Humans; D010974:Platelet Aggregation / Q000502:physiology; D013577:Syndrome
D001779:Blood Coagulation Factors; D005343:Fibrinolytic Agents